CA2241129A1 - Therapeutic compositions - Google Patents

Therapeutic compositions Download PDF

Info

Publication number
CA2241129A1
CA2241129A1 CA002241129A CA2241129A CA2241129A1 CA 2241129 A1 CA2241129 A1 CA 2241129A1 CA 002241129 A CA002241129 A CA 002241129A CA 2241129 A CA2241129 A CA 2241129A CA 2241129 A1 CA2241129 A1 CA 2241129A1
Authority
CA
Canada
Prior art keywords
leu
ser
glu
seq
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002241129A
Other languages
English (en)
French (fr)
Inventor
David Laurence Vaux
Christine Joy Hawkins
Anthony Gerald Uren
Miha Pakusch
Kirsten Louise Puls
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerylid Pty Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2241129A1 publication Critical patent/CA2241129A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002241129A 1995-12-22 1996-12-20 Therapeutic compositions Abandoned CA2241129A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN7275 1995-12-22
AUPN7275A AUPN727595A0 (en) 1995-12-22 1995-12-22 Therapeutic compositions

Publications (1)

Publication Number Publication Date
CA2241129A1 true CA2241129A1 (en) 1997-07-03

Family

ID=3791594

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002241129A Abandoned CA2241129A1 (en) 1995-12-22 1996-12-20 Therapeutic compositions

Country Status (5)

Country Link
EP (1) EP0868430A4 (de)
JP (1) JP2000504932A (de)
AU (2) AUPN727595A0 (de)
CA (1) CA2241129A1 (de)
WO (1) WO1997023501A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156535A (en) * 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
CA2320513A1 (en) 1998-02-11 1999-08-19 Joseph T. Bruder Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
EP1490490B1 (de) 2002-03-27 2009-05-13 Aegera Therapeutics Inc. Gegen iap gerichtete antisense-nukleobasen und deren verwendungen
US8012944B2 (en) 2003-10-30 2011-09-06 Pharmascience Inc. Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent
TWI543988B (zh) * 2006-03-16 2016-08-01 科學製藥股份有限公司 結合於細胞凋亡抑制蛋白（ｉａｐ）之桿狀病毒ｉａｐ重複序列（ｂｉｒ）區域之化合物
WO2024105193A1 (en) 2022-11-17 2024-05-23 Koptyug Andrey V Novel compounds and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025694A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Inhibitors of ced-3 and related proteins
US5646008A (en) * 1993-06-22 1997-07-08 The Regent Of The University Of Michigan Vertebrate apoptosis gene: compositions and methods
EP0711174A4 (de) * 1993-06-24 1997-11-12 Gen Hospital Corp Gene für den programmierten zelltod und proteine
EP0830375A4 (de) * 1995-05-11 2001-11-21 Human Genome Sciences Inc Menschlicher inhibitor des apoptosegens 1
US6156535A (en) * 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods

Also Published As

Publication number Publication date
WO1997023501A1 (en) 1997-07-03
EP0868430A1 (de) 1998-10-07
EP0868430A4 (de) 2002-08-07
AU710221B2 (en) 1999-09-16
JP2000504932A (ja) 2000-04-25
AUPN727595A0 (en) 1996-01-18
AU1089197A (en) 1997-07-17

Similar Documents

Publication Publication Date Title
US7994128B2 (en) Conotoxin peptides useful as inhibitors of neuronal amine transporters
WO1998053061A1 (en) Three novel genes encoding a zinc finger protein, a guanine, nucleotide exchange factor and a heat shock protein or heat shock binding protein
CA2241129A1 (en) Therapeutic compositions
US7572900B2 (en) Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
CA2250207A1 (en) A novel mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
US7078174B1 (en) Screening methods using SOCS box-containing peptides
US20060194233A1 (en) Ligand of the protein "beacon"
US6849601B1 (en) Peptides
WO1998034951A1 (en) A new cytokine family and uses thereof
AU774097B2 (en) A novel regulatory molecule and genetic sequences encoding same
ZA200305965B (en) Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals
US6884617B1 (en) Isolated nucleic acid encoding murine musculin
AU728863B2 (en) A novel mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
AU774178B2 (en) A ligand of the protein "beacon"
AU711646B2 (en) Novel receptor ligands and genetic sequences encoding same
US7192576B1 (en) Biologically active complex of NR6 and cardiotrophin-like-cytokine
AU752360B2 (en) Novel therapeutic molecules
AU741708B2 (en) A new cytokine family and uses thereof
AU6453099A (en) Novel peptides
AU2002304971A1 (en) Bcl-2-modifying factor (Bmf) sequences and their use in modulating apoptosis

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued